Chronic lung disease in HIV-infected children established on antiretroviral therapy

Chronic lung disease in HIV-infected children established on antiretroviral therapy

Respiratory disease is a major cause of morbidity and mortality in HIV-infected children. Despite antiretroviral therapy (ART), children suffer chronic symptoms. We investigated symptom prevalence, lung function, and exercise capacity among older children established on ART, and an age-matched HIV-u...

Full description

Bibliographic Details
Main Authors:	Rylance, J, Mchugh, G, Metcalfe, J, Mujuru, H, Nathoo, K, Wilmore, S, Rowland-Jones, S, Majonga, E, Kranzer, K, Ferrand, R
Format:	Journal article
Language:	English
Published:	Lippincott, Williams & Wilkins 2016

Similar Items

Effect of antiretroviral therapy on longitudinal lung function trends in older children and adolescents with HIV-infection.
by: Sarah Rylance, et al.
Published: (2019-01-01)

CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence
by: Simms, V, et al.
Published: (2018)

Shorter granulocyte telomeres among children and adolescents with perinatally-acquired HIV infection and chronic lung disease in Zimbabwe
by: Ajaykumar, A, et al.
Published: (2020)

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.
by: Gonzalez-Martinez, C, et al.
Published: (2017)

History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children
by: Sovershaeva, E, et al.
Published: (2019)

Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy
by: Frigati, LJ, et al.
Published: (2020)

Growth improvement following antiretroviral therapy initiation in children with perinatally-acquired HIV diagnosed in older childhood in Zimbabwe: a prospective cohort study
by: Victoria Simms, et al.
Published: (2022-07-01)

The effect of azithromycin for management of HIV-associated chronic lung disease on right heart function: Results from the BREATHE trial
by: Edith D. Majonga, et al.
Published: (2021-12-01)

Distinct lung microbiota associate with HIV-associated chronic lung disease in children
by: Sudha Bhadriraju, et al.
Published: (2020-09-01)

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial
by: Carmen Gonzalez-Martinez, et al.
Published: (2017-12-01)

Unexpectedly high prevalence of cytomegalovirus DNAemia in older children and adolescents with perinatally acquired human immunodeficiency virus infection
by: Yindom, L, et al.
Published: (2019)

Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy
by: Andrea M. Rehman, et al.
Published: (2022-01-01)

Adherence to additional medication for management of HIV-associated comorbidities among older children and adolescents taking antiretroviral therapy.
by: Andrea M Rehman, et al.
Published: (2022-01-01)

Vitamin D 3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial
by: Dzavakwa, NV, et al.
Published: (2022)

Update: Vitamin D 3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial
by: Dzavakwa, NV, et al.
Published: (2024)

Effect of community-based HIV counselling and testing on HIV incidence
by: Rashida A Ferrand, et al.
Published: (2014-05-01)

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.
by: Peterson, K, et al.
Published: (2011)

Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection
by: Hameiri-Bowen, D, et al.
Published: (2021)

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
by: Peterson, I, et al.
Published: (2011)

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia.
by: Peterson, I, et al.
Published: (2011)

Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
by: Hakim, J, et al.
Published: (2017)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
by: Szubert, A, et al.
Published: (2015)

Reappearance of HIV antibody in an infected, seronegative individual after treatment with highly active antiretroviral therapy.
by: Rice, P, et al.
Published: (1999)

Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.
by: Katharina Kranzer, et al.
Published: (2010-11-01)

Association Between Vitamin D Insufficiency and Impaired Bone Density Among Adolescents With Perinatally Acquired HIV Infection
by: Dzavakwa, NV, et al.
Published: (2024)

Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease
by: Regina E. Abotsi, et al.
Published: (2021-02-01)

Ethambutol Toxicity in HIV Patients on Antiretroviral Therapy
by: K K Vyas, J P S Nalva
Published: (2023-10-01)

A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.
by: Gottlieb, G, et al.
Published: (2008)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
by: Walker, A, et al.
Published: (2012)

Missed opportunities for HIV testing of children in a high prevalence setting
by: K. Kidia, et al.
Published: (2014-04-01)

Barriers to provider-initiated testing and counselling for children in a high HIV prevalence setting: a mixed methods study.
by: Katharina Kranzer, et al.
Published: (2014-05-01)

Provider-initiated HIV testing & counseling (PITC) in children: Tacking the P of PITC
by: K. Kidia, et al.
Published: (2014-04-01)

Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.
by: Rashida A Ferrand, et al.
Published: (2010-02-01)

Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy
by: Jallow, S, et al.
Published: (2006)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
by: Musoke, P, et al.
Published: (2015)

Cytomegalovirus-specific immunoglobulin G is associated with chronic lung disease in children and adolescents from sub-Saharan Africa living with perinatal human immunodeficiency virus
by: Hameiri Bowen, D, et al.
Published: (2020)

HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy.
by: Jambo, K, et al.
Published: (2017)

Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe
by: Evgeniya Sovershaeva, et al.
Published: (2019-01-01)

Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa
by: Nglazi Mweete D, et al.
Published: (2012-01-01)